GS
GelStat Corporation
GSAC · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $185.4K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0003
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GSAC is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.49x
P/FFO N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 267.92%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 73.35%
Op. margin 113.65%
FCF margin 10.47%
Quality
78 /100
Excellent ROA 87.03%
Asset turnover 1.19x
ROIC 122.49%
Debt
0 /100
High Int. coverage -2.32x
Current ratio 0.30x
Net debt/EBITDA N/A
Stability
14 /100
Unstable Rev. volatility 3,624.64%
EPS volatility 60.09%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GSAC
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Javier G. Acosta
Employees
2
Headquarters
Palm City